This page is specifically intended to support patients who have been prescribed Luforbec by their healthcare professional.
Luforbec is an inhaler containing the active substances beclometasone and formoterol. The device delivers the active substances to the lungs to help manage the respiratory conditions asthma and chronic obstructive pulmonary disease, otherwise known as COPD.
Beclometasone – belongs to a group of medicines called corticosteroids which have an anti-inflammatory action reducing the swelling and irritation in your lungs.
Formoterol – belongs to a group of medicines called long-acting bronchodilators which relax the muscles in your airways.
Together these two active substances make breathing easier, by providing relief from symptoms such as shortness of breath, chest tightness, wheezing and cough.
If you are allergic or think you are allergic to any of the ingredients of Luforbec,
contact your healthcare professional for advice.
User Guide Videos
How to use Luforbec
How to use Luforbec with a spacer device
How to look after your Luforbec device
Patient User Guides
Reporting of side effects
You can help by reporting any side effects you may get. If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/.
By reporting side effects you can help provide more information on the safety of this medicine.
LUP-CORP-005s DOP: December 2020